Autopsy report · NCT03624192
RES Prepared With RECELL® Compared to Conventional Care for Healing of Donor Sites in Ages 1-16 Years
Cause of deathStaffing, sites or logistics
“Study closed in response to COVID-19 and overall program objectives.”
Life of this trial
- Registered 2 months before it started.
- Ran for about 1 year 4 months before it stopped.
- 3 participants enrolled.
- Results were posted on the registry 1 year 6 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Avita Medical
- Sponsor type
- Industry
- Conditions
- Skin; Deformity
- Interventions
- RECELL® Autologous Cell Harvesting Device; Telfa™ Clear and Xeroform™ dressings
- Participants
- 3
- Sites
- 7
- Countries
- United States
Trials that died the same way
- The Impact of Imprinting and Repeated Influenza Vaccination on Adaptive Immunity, Transcriptomics, and Metabolomics
“The study closed prior to completing year 3 of the study due to the COVID-19 pandemic.” - Effects of Short-term Choir Participation on Auditory Perception in Hearing-aided Older Adults.
“COVID-19 forced the shut down of the study” - A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors
“The study was terminated early due to the COVID-19 pandemic and sponsor's funding constraints, based on promising preliminary safety and efficacy data.” - The Efficacy of Denosumab in Incomplete Patients Spinal Cord Injury
“Study ended early due to COVID-19” - Autologous Stem/Stromal Cellular Stromal Vascular Fraction (cSVF) In Frailty-Aging Processes
“COVID -19 closed facility and testing of subjects”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.